Cargando…
Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia [Retraction]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096412/ https://www.ncbi.nlm.nih.gov/pubmed/33958898 http://dx.doi.org/10.2147/HIV.S316675 |
Ejemplares similares
-
Determinants of Drug-Induced Hepatotoxicity Among Patients with Human Immunodeficiency Virus Taking a High Dose of Rifapentine Plus Isoniazid Drugs at the All Africa Leprosy Tuberculosis Rehabilitation and Training Center in Addis Ababa, Ethiopia
por: Lisanwork Arage, Leuel, et al.
Publicado: (2021) -
Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques
Publicado: (2021) -
Provision and awareness for isoniazid preventive therapy among PLHIV in Addis Ababa, Ethiopia
por: Wesen, Amenu, et al.
Publicado: (2012) -
Retraction Note: Sexual reproductive health service utilization and associated factors among undergraduate students of Addis Ababa University in Ethiopia
por: Mekbib, Bethel, et al.
Publicado: (2023) -
Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis
por: Yu, Ya-Yen, et al.
Publicado: (2019)